Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Detailed pharmacokinetics, pharmacodynamics and toxicokinetics reported for CI-1027

Nov. 18, 1999

Pharmacokinetics of CP-331684 investigated in animal species

Nov. 18, 1999

AAPS presentation for new beta3-adrenoceptor agonist: preclinical PK/PD of GW-0604

Nov. 18, 1999

FDA requests confirmatory trial of Aldurazyme prior to BLA filing

Nov. 18, 1999

Wide series of GH-stimulating compounds presented by Novo Nordisk

Nov. 18, 1999

Merck synthesizes novel oxytocin receptor antagonists with piperazine structure

Nov. 17, 1999

GelTex and Sankyo sign letter of intent for marketing CholestaGel and second-generation product

Nov. 17, 1999

OGS renegotiates license agreement with Searle for OGT-918

Nov. 17, 1999

Vitronectin receptor antagonists for bone disorders, etc., in development at AHP

Nov. 15, 1999

NovoRapid now on the market in the U.K.

Nov. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...